Apogee (NASDAQ:APOG) Therapeutics, Inc. (APGE), a biotechnology company specializing in biological products with a market capitalization of $2.2 billion, has entered into a significant agreement ...

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Apogee (NASDAQ:APOG) Therapeutics, Inc. (APGE), a biotechnology company specializing in biological products with a market capitalization of $2.2 billion, has entered into a significant agreement with ...